Tehran Darou Pharmaceutical EGM, Dividend Decision
Tehran Darou Pharmaceutical's (symbol Dtehran) extraordinary ordinary general meeting is scheduled for 11:00 on Monday, 31 August 2026 (9 Shahrivar 1405) in Tehran. The agenda includes approving financial statements for the year ended 19 March 2026 and a dividend decision.
Related events
Secondary Trading Begins for Two New IME Silver Funds, Yas and Silva
The Iran Mercantile Exchange's derivatives and new financial instruments management announced that secondary trading begins for two new silver investment funds, Toranj 1 under the ticker Yas and Padash 1 under the ticker Silva, on Monday, 16 Shahrivar 1405 (September 8, 2026), from 11:45am to 6pm. Trading in both funds is available online through licensed brokers, with a daily price band of 10 percent from the prior day's closing price.
Extraordinary General Meeting — MEAZ
Assembly invitation filed on Codal.
Ordinary General Meeting — DCAZ
Assembly decisions filed on Codal.
Ordinary General Meeting — Bourse Iran Joint Investment Fund
Boursiran Mutual Fund has invited holders of its preferred units to a meeting at 10:00 on Friday, September 4, 2026 in Tehran. The agenda is a decision on extending the fund's operating term.
Ordinary General Meeting — RT03
Assembly decisions filed on Codal.